Skip to main content

1 Result(s)

within Lan Beppu Remove this filter Biomedicine Remove this filter

and

  1. Article

    Open Access

    Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia

    We evaluated BCR-ABL1 kinetics in patients treated with nilotinib and analyzed whether a dynamic model of changes in BCR-ABL1 levels over time could be used to predict long-term responses.

    Andrew M Stein, Giovanni Martinelli, Timothy P Hughes, Martin C Müller… in BMC Cancer (2013)

    Download PDF (579 KB) View Article